SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Katharina Kieslich, Jesse B. Bump, Ole Frithjof Norheim, Sripen Tantivess, Peter Littlejohns, Accounting for Technical, Ethical, and Political Factors in Priority Setting, Health Systems & Reform, 2016, 2, 1, 51

    CrossRef

  2. You have free access to this content2
    Ulla Kou Griffiths, Rosa Legood, Catherine Pitt, Comparison of Economic Evaluation Methods Across Low-income, Middle-income and High-income Countries: What are the Differences and Why?, Health Economics, 2016, 25,
  3. 3
    DL Veenstra, The value of routine pharmacogenomic screening—Are we there yet? A perspective on the costs and benefits of routine screening—shouldn't everyone have this done?, Clinical Pharmacology & Therapeutics, 2016, 99, 2
  4. 4
    Barbara Błaszczyk, Władysław Lasoń, Stanisław Jerzy Czuczwar, Antiepileptic drugs and adverse skin reactions: An update, Pharmacological Reports, 2015, 67, 3, 426

    CrossRef

  5. 5
    Catrin O. Plumpton, Vincent L. M. Yip, Ana Alfirevic, Anthony G. Marson, Munir Pirmohamed, Dyfrig A. Hughes, Cost-effectiveness of screening for HLA-A*31:01 prior to initiation of carbamazepine in epilepsy, Epilepsia, 2015, 56, 4
  6. 6
    T. A. Manolio, M. Abramowicz, F. Al-Mulla, W. Anderson, R. Balling, A. C. Berger, S. Bleyl, A. Chakravarti, W. Chantratita, R. L. Chisholm, V. H. W. Dissanayake, M. Dunn, V. J. Dzau, B.-G. Han, T. Hubbard, A. Kolbe, B. Korf, M. Kubo, P. Lasko, E. Leego, S. Mahasirimongkol, P. P. Majumdar, G. Matthijs, H. L. McLeod, A. Metspalu, P. Meulien, S. Miyano, Y. Naparstek, P. P. O'Rourke, G. P. Patrinos, H. L. Rehm, M. V. Relling, G. Rennert, L. L. Rodriguez, D. M. Roden, A. R. Shuldiner, S. Sinha, P. Tan, M. Ulfendahl, R. Ward, M. S. Williams, J. E. L. Wong, E. D. Green, G. S. Ginsburg, Global implementation of genomic medicine: We are not alone, Science Translational Medicine, 2015, 7, 290, 290ps13

    CrossRef

  7. 7
    L. E. Walker, N. Mirza, V. L. M. Yip, A. G. Marson, M. Pirmohamed, Personalized medicine approaches in epilepsy, Journal of Internal Medicine, 2015, 277, 2
  8. 8
    Mary V. Relling, William E. Evans, Pharmacogenomics in the clinic, Nature, 2015, 526, 7573, 343

    CrossRef

  9. 9
    Konstantinos Mitropoulos, Hayat Al Jaibeji, Diego A. Forero, Paul Laissue, Ambroise Wonkam, Catalina Lopez-Correa, Zahurin Mohamed, Wasun Chantratita, Ming Ta Michael Lee, Adrian Llerena, Angela Brand, Bassam R. Ali, George P. Patrinos, Success stories in genomic medicine from resource-limited countries, Human Genomics, 2015, 9, 1

    CrossRef

  10. 10
    Brian Spoelhof, Lynn Frendak, Lucia Rivera Lara, A worldwide yearly survey of new data in adverse drug reactions, 2015,

    CrossRef

  11. 11
    Vorasuk Shotelersuk, Chanin Limwongse, Surakameth Mahasirimongkol, Genetics and genomics in Thailand: challenges and opportunities, Molecular Genetics & Genomic Medicine, 2014, 2, 3